These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 11025624

  • 1. A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis.
    Rao BS, Das DG, Taraknath VR, Sarma Y.
    Neurol India; 2000 Sep; 48(3):223-6. PubMed ID: 11025624
    [Abstract] [Full Text] [Related]

  • 2. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S, Erfani S, Mohammadi MR, Tehrani-Doost M, Amini H, Gudarzi SS, Yasamy MT.
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [Abstract] [Full Text] [Related]

  • 3. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study.
    Gerber WD, Schellenberg R, Thom M, Haufe C, Bölsche F, Wedekind W, Niederberger U, Soyka D.
    Funct Neurol; 1995 Apr; 10(1):27-35. PubMed ID: 7649498
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of the effect of 5-hydroxytryptophan and propranolol in the interval treatment of migraine].
    Maissen CP, Ludin HP.
    Schweiz Med Wochenschr; 1991 Oct 26; 121(43):1585-90. PubMed ID: 1947955
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine.
    Gawel MJ, Kreeft J, Nelson RF, Simard D, Arnott WS.
    Can J Neurol Sci; 1992 Aug 26; 19(3):340-5. PubMed ID: 1393843
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK, Mathew N, Diener HC, Hu P, Haas M, Novak GP, Study Group.
    Headache; 2009 Feb 26; 49(2):216-26. PubMed ID: 19222595
    [Abstract] [Full Text] [Related]

  • 7. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA.
    Headache; 2006 Jan 26; 46(1):115-24. PubMed ID: 16412159
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 26; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 9. Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group.
    Diener HC, Föh M, Iaccarino C, Wessely P, Isler H, Strenge H, Fischer M, Wedekind W, Taneri Z.
    Cephalalgia; 1996 Oct 26; 16(6):441-7. PubMed ID: 8902255
    [Abstract] [Full Text] [Related]

  • 10. Biofeedback assisted diaphragmatic breathing and systematic relaxation versus propranolol in long term prophylaxis of migraine.
    Kaushik R, Kaushik RM, Mahajan SK, Rajesh V.
    Complement Ther Med; 2005 Sep 26; 13(3):165-74. PubMed ID: 16150370
    [Abstract] [Full Text] [Related]

  • 11. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
    Ashtari F, Shaygannejad V, Akbari M.
    Acta Neurol Scand; 2008 Nov 26; 118(5):301-5. PubMed ID: 18713156
    [Abstract] [Full Text] [Related]

  • 12. Rofecoxib versus ibuprofen for acute treatment of migraine: a randomised placebo controlled trial.
    Misra UK, Jose M, Kalita J.
    Postgrad Med J; 2004 Dec 26; 80(950):720-3. PubMed ID: 15579612
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
    Kampman KM, Dackis C, Lynch KG, Pettinati H, Tirado C, Gariti P, Sparkman T, Atzram M, O'Brien CP.
    Drug Alcohol Depend; 2006 Nov 08; 85(2):129-37. PubMed ID: 16697124
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr 08; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 15. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr 08; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 16. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study.
    Honkaniemi J, Liimatainen S, Rainesalo S, Sulavuori S.
    Headache; 2006 May 08; 46(5):781-7. PubMed ID: 16643581
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J, Cady R, Singer R, Peters K, Webster C, Kori S, Byrd S.
    Clin Ther; 2006 Apr 08; 28(4):517-26. PubMed ID: 16750463
    [Abstract] [Full Text] [Related]

  • 18. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ.
    Headache; 2005 Sep 08; 45(8):983-91. PubMed ID: 16109111
    [Abstract] [Full Text] [Related]

  • 19. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
    Brandes JL, Visser WH, Farmer MV, Schuhl AL, Malbecq W, Vrijens F, Lines CR, Reines SA, Protocol 125 study group.
    Headache; 2004 Jun 08; 44(6):581-6. PubMed ID: 15186302
    [Abstract] [Full Text] [Related]

  • 20. [Beta-blockers and migraine. Efficacy of time-release propranolol versus placebo].
    Pradalier A, Serratrice G, Collard M, Hirsch E, Feve J, Masson M, Masson C, Dry J, Koulikovsky G, Nguyen G.
    Therapie; 1990 Jun 08; 45(5):441-5. PubMed ID: 2260046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.